Doğrulama için verilen süre doldu. Lütfen yenileyin.

Şifremi Unuttum

ABD Hükümetinden Yeni Antibiyotik Geliştirilmesine Mali Destek


Dept of Health and Human Services, AstraZeneca to develop antibiotics


Wed Sep 16, 2015

The U.S. Department of Health and Human Services (HHS) said on Wednesday it signed a deal with British drugmaker AstraZenaca Plc to develop antibiotics.

The federal agency said it will share costs with AstraZeneca to develop a portfolio of drugs to treat illnesses caused by bioterrorism agents and antibiotic-resistant infections.

The Biomedical Advanced Research and Development Authority of the HHS will initially provide $50 million, and could pay up to $170 million for development of additional products as part of the deal, which is for five years.

The first drug candidate to be explored is a combination of two antibiotics, Aztreonam and Avibactam, known together as ATM-AVI, the HHS said.

The combination ATM-AVI is being tested in Europe in a mid-stage study, the agency said. (Reporting by Vidya L Nathan in Bengaluru; Editing by Sriraj Kalluvila)